Allarity Therapeutics, Inc. ( ($ALLR) ) has issued an announcement. Allarity Therapeutics, a clinical-stage pharmaceutical company, has bolstered its leadership with the appointment of Jeremy R. Graff, Ph.D., as President
Allarity Therapeutics, Inc. ( ($ALLR) ) has issued an announcement. Allarity Therapeutics, a clinical-stage pharmaceutical company, has bolstered its leadership with the appointment of Jeremy R. Graff, Ph.D., as President
Allarity Therapeutics, Inc. ( ($ALLR) ) has provided an update. Allarity Therapeutics has announced a significant milestone in its Phase 2 clinical trial for stenoparib, a novel treatment for advanced
המטופלים הללו נבחרו משום שבדיקה מיוחדת בשם מנבא התגובה לתרופה הראתה שסביר להניח שהם ירוויחו רבות מסטנופריב. התרופה הזו היא סוג חדש שחוסם שני חלקים ספציפיים בתאי הסרטן, אשר עשוי
Allarity Therapeutics announced that two patients enrolled in its Phase 2 clinical trial of stenoparib for advanced, recurrent ovarian cancer have now exceeded one year on therapy. The patients had
Allarity Therapeutics, Inc. ( ($ALLR) ) just unveiled an announcement. Allarity Therapeutics, Inc. has updated its financing strategy by amending an agreement to potentially sell up to $50 million in